Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-20

Clinical Trial Update: A Study of Taurine in Patients With First-episode Psychosis Receiving Antipsychotic Treatment [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating taurine in patients with first-episode psychosis who are receiving antipsychotic treatment has completed. The study was sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Taurine (taurine)

Snippet

Sponsor: Melbourne Health | Conditions: Psychotic Disorders | Phase 2, Phase 3 | Status: COMPLETED